158 related articles for article (PubMed ID: 36059148)
1. Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma.
Szabó B; Németh K; Mészáros K; Krokker L; Likó I; Saskői É; Németh K; Szabó PT; Szücs N; Czirják S; Szalóki G; Patócs A; Butz H
J Clin Endocrinol Metab; 2022 Nov; 107(11):3066-3079. PubMed ID: 36059148
[TBL] [Abstract][Full Text] [Related]
2. Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior.
Szabó B; Németh K; Mészáros K; Szücs N; Czirják S; Reiniger L; Rajnai H; Krencz I; Karászi K; Krokker L; Patócs A; Butz H
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32232382
[TBL] [Abstract][Full Text] [Related]
3. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
4. E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.
Zhou C; Wawrowsky K; Bannykh S; Gutman S; Melmed S
Mol Endocrinol; 2009 Dec; 23(12):2000-12. PubMed ID: 19837943
[TBL] [Abstract][Full Text] [Related]
5. SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth
Wang X; Fang Y; Zhou Y; Guo X; Xu K; Li C; Zhang J; Hong Y
Front Endocrinol (Lausanne); 2020; 11():566761. PubMed ID: 33362712
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors.
Gil J; Marques-Pamies M; Valassi E; Serra G; Salinas I; Xifra G; Casano-Sancho P; Carrato C; Biagetti B; Sesmilo G; Marcos-Ruiz J; Rodriguez-Lloveras H; Rueda-Pujol A; Aulinas A; Blanco A; Hostalot C; Simó-Servat A; Muñoz F; Rico M; Ibáñez-Domínguez J; Cordero E; Webb SM; Jordà M; Puig-Domingo M
Front Endocrinol (Lausanne); 2023; 14():1129213. PubMed ID: 37033229
[TBL] [Abstract][Full Text] [Related]
7. Changes in DNA 5-Hydroxymethylcytosine Levels and the Underlying Mechanism in Non-functioning Pituitary Adenomas.
Xu Y; Niu Y; Deng K; Pan H; Feng F; Gong F; Tong WM; Chen S; Lu L; Wang R; You H; Yao Y; Zhu H
Front Endocrinol (Lausanne); 2020; 11():361. PubMed ID: 32774324
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression.
Huang J; Zhang F; Hu G; Pan Y; Sun W; Jiang L; Wang P; Qiu J; Ding X
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35730625
[TBL] [Abstract][Full Text] [Related]
9. Evidence for TET-mediated DNA demethylation as an epigenetic alteration in cumulus granulosa cells of women with polycystic ovary syndrome.
Sagvekar P; Shinde G; Mangoli V; Desai SK; Mukherjee S
Mol Hum Reprod; 2022 Jun; 28(7):. PubMed ID: 35640568
[TBL] [Abstract][Full Text] [Related]
10. Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression.
Horwitz GA; Miklovsky I; Heaney AP; Ren SG; Melmed S
Mol Endocrinol; 2003 Apr; 17(4):600-9. PubMed ID: 12554778
[TBL] [Abstract][Full Text] [Related]
11. Pituitary tumor transforming gene-1 haplotypes and risk of pituitary adenoma: a case-control study.
Chen S; Xiao L; Liu Z; Liu J; Liu Y
BMC Med Genet; 2011 Mar; 12():44. PubMed ID: 21439054
[TBL] [Abstract][Full Text] [Related]
12. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.
Ji C; Nagaoka K; Zou J; Casulli S; Lu S; Cao KY; Zhang H; Iwagami Y; Carlson RI; Brooks K; Lawrence J; Mueller W; Wands JR; Huang CK
FASEB J; 2019 Feb; 33(2):1824-1835. PubMed ID: 30188753
[TBL] [Abstract][Full Text] [Related]
13. ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.
Zhi T; Jiang K; Xu X; Yu T; Zhou F; Wang Y; Liu N; Zhang J
Neuro Oncol; 2019 Mar; 21(4):462-473. PubMed ID: 30590814
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and potential regulatory mechanism of overexpression of pituitary tumor-transforming gene transcription factor in bladder cancer.
Li JD; Farah AA; Huang ZG; Zhai GQ; Wang RG; Liu JL; Wang QJ; Zhang GL; Lei ZL; Dang YW; Li SH
BMC Cancer; 2022 Jun; 22(1):713. PubMed ID: 35768832
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas.
Fu D; Zhang Y; Cui H
Am J Cancer Res; 2018; 8(2):245-255. PubMed ID: 29511595
[TBL] [Abstract][Full Text] [Related]
16. Effects of ten-eleven translocation 1 (Tet1) on DNA methylation and gene expression in chicken primordial germ cells.
Yu M; Li D; Cao W; Chen X; Du W
Reprod Fertil Dev; 2019 Mar; 31(3):509-520. PubMed ID: 30282572
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma.
Barazeghi E; Gill AJ; Sidhu S; Norlén O; Dina R; Palazzo FF; Hellman P; Stålberg P; Westin G
Clin Epigenetics; 2016; 8():31. PubMed ID: 26973719
[TBL] [Abstract][Full Text] [Related]
18. PRIMA-1 selectively induces global DNA demethylation in p53 mutant-type thyroid cancer cells.
Qiang W; Jin T; Yang Q; Liu W; Liu S; Ji M; He N; Chen C; Shi B; Hou P
J Biomed Nanotechnol; 2014 Jul; 10(7):1249-58. PubMed ID: 24804545
[TBL] [Abstract][Full Text] [Related]
19. TET1 promotes RXRα expression and adipogenesis through DNA demethylation.
Qian H; Zhao J; Yang X; Wu S; An Y; Qu Y; Li Z; Ge H; Li E; Qi W
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jun; 1866(6):158919. PubMed ID: 33684567
[TBL] [Abstract][Full Text] [Related]
20. Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma.
Sajadian SO; Ehnert S; Vakilian H; Koutsouraki E; Damm G; Seehofer D; Thasler W; Dooley S; Baharvand H; Sipos B; Nussler AK
Clin Epigenetics; 2015; 7(1):98. PubMed ID: 26366235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]